Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nexgel (NXGLW) EBIT (2018 - 2025)

Nexgel's EBIT history spans 8 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, EBIT rose 281.93% year-over-year to $1.5 million; the TTM value through Dec 2025 reached -$608000.0, up 82.89%, while the annual FY2025 figure was -$608000.0, 82.89% up from the prior year.
  • EBIT reached $1.5 million in Q4 2025 per NXGLW's latest filing, up from -$725000.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $1.5 million in Q4 2025 to a low of -$1.2 million in Q4 2023.
  • Average EBIT over 5 years is -$677800.0, with a median of -$779000.0 recorded in 2022.
  • Peak YoY movement for EBIT: plummeted 70.0% in 2022, then surged 281.93% in 2025.
  • A 5-year view of EBIT shows it stood at -$887000.0 in 2021, then grew by 11.95% to -$781000.0 in 2022, then crashed by 56.08% to -$1.2 million in 2023, then skyrocketed by 31.01% to -$841000.0 in 2024, then soared by 281.93% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for NXGLW's EBIT are $1.5 million (Q4 2025), -$725000.0 (Q3 2025), and -$636000.0 (Q2 2025).